Beijing Huanxing Cancer Hospital
2 clinical trials · Sponsor
◉ Watch Beijing Huanxing Cancer Hospital
| Record | Firm | Date |
|---|---|---|
| Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma (NCT03389438) | Beijing Huanxing Cancer Hospital | 2018-02-26 |
Track Beijing Huanxing Cancer Hospital automatically
Every clearance here is in the API, with alerts when new ones post.